Χώρα: Σουηδία
Γλώσσα: Σουηδικά
Πηγή: Läkemedelsverket (Medical Products Agency)
gabapentin
Orifarm AB
N02BF01
gabapentin
600 mg
Filmdragerad tablett
gabapentin 600 mg Aktiv substans
Receptbelagt
Förpacknings: Blister, 100 tabletter
Avregistrerad
2017-04-05
PACKAGE LEAFLET: INFORMATION FOR THE USER GABAPENTIN RIVOPHARM 600 MG FILM-COATED TABLETS GABAPENTIN RIVOPHARM 800 MG FILM-COATED TABLETS Gabapentin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What GABAPENTIN RIVOPHARM is and what it is used for 2. What you need to know before you take GABAPENTIN RIVOPHARM 3. How to take GABAPENTIN RIVOPHARM 4. Possible side effects 5. How to store GABAPENTIN RIVOPHARM 6. Contents of the pack and other information 1. WHAT GABAPENTIN RIVOPHARM IS AND WHAT IT IS USED FOR Gabapentin Rivopharm belongs to a group of medicines used to treat epilepsy and peripheral neuropathic pain (long-lasting pain caused by damage to the nerves). The active substance in Gabapentin Rivopharm is gabapentin. Gabapentin Rivopharm is used to treat: - various forms of epilepsy (seizures that are initially limited to certain parts of the brain, whether the seizure spreads to other parts of the brain or not). Your doctor will prescribe Gabapentin Rivopharm for you to help treat your epilepsy when your current treatment is not fully controlling your condition. You should take Gabapentin Rivopharm in addition to your current treatment unless told otherwise. Gabapentin Rivopharm can also be used on its own to treat adults and children over 12 years of age. - peripheral neuropathic pain (long-lasting pain caused by damage to the nerves). A variety of different diseases can cause peripheral neuropathic pain (primarily occurring in the legs and/or arms), such as diabetes or shingles. Pain sensati Διαβάστε το πλήρες έγγραφο
Gabapentin Rivopharm 600 mg film-coated tablets Gabapentin Rivopharm 800 mg film-coated tablets Gabapentin Rivopharm 600 mg film-coated tablets Each film-coated tablet contains 600 mg gabapentin. Gabapentin Rivopharm 800 mg film-coated tablets Each film-coated tablet contains 800 mg gabapentin. Gabapentin Rivopharm 600 mg film-coated tablets White to off-white, oval shaped, bevelled edged, film-coated tablet. On one side engraved “7173”, and on the other side engraved “93”. Gabapentin Rivopharm 800 mg film-coated tablets White to off-white, oval shaped, bevelled edged, film-coated tablet. On one side engraved “7174”, and on the other side engraved “93”. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT 2. QUALITATIVE AND QUANTITATIVE COMPOSITION For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Epilepsy Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and children aged 6 years and above (see section 5.1). Gabapentin is indicated as monotherapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents aged 12 years and above. Treatment of peripheral neuropathic pain Gabapentin is indicated for the treatment of peripheral neuropathic pain such as painful diabetic neuropathy and post-herpetic neuralgia in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology For all indications a titration scheme for the initiation of therapy is described in Table 1, which is recommended for adults and adolescents aged 12 years and above. Dosing instructions for children under 12 years of age are provided under a separate sub-heading later in this section. For lower dosages, which cannot be applied with these strengths, other strengths and dosage forms are available. Table 1 DOSING CHART - INITIAL TITRATION Day 1 Day 2 Day 3 300 mg once a day 300 mg two times a day 300 mg Διαβάστε το πλήρες έγγραφο